Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter npt2b+/-mice

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 5, 2011, Pages

  Ohi, Akiko ^a   Hanabusa, Etsuyo ^a   Ueda, Otoya ^b   Segawa, Hiroko ^a   Horiba, Naoshi ^b   Kaneko, Ichiro ^a   Kuwahara, Shoji ^a   Mukai, Tomo ^a   Sasaki, Shohei ^a   Tominaga, Rieko ^a   Furutani, Junya ^a   Aranami, Fumito ^a   Ohtomo, Shuichi ^b   Oikawa, Yumiko ^c   Kawase, Yousuke ^c   Wada, Naoko A ^c   Tachibe, Takanori ^c   Kakefuda, Mami ^c   Tateishi, Hiromi ^c   Matsumoto, Kaoru ^c   Tatsumi, Sawako ^a   Kido, Shinsuke ^a   Fukushima, Naoshi ^b   Jishage, Kou ichi ^b,c   Miyamoto, Ken ichi ^a   more..

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^c Chugai Research Institute for Medical Science Inc   (Japan)

Author keywords

Intestine; Mouse; Phosphate; Slc34a2; Transporter

Indexed keywords

ADENINE; CALCITRIOL; CREATININE; FIBROBLAST GROWTH FACTOR 23; MESSENGER RNA; PHOSPHATE; SODIUM PHOSPHATE COTRANSPORTER 2B; SODIUM PHOSPHATE COTRANSPORTER 2C;

ANIMAL CELL; ARTICLE; CALCIFICATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; HEMODIALYSIS; HOMEOSTASIS; HUMAN; HYPERPHOSPHATEMIA; HYPOPHOSPHATEMIA; IMPLANTATION; INTESTINE; KIDNEY FAILURE; MALE; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHATURIA; PRIORITY JOURNAL; PROTEIN BINDING; URINARY EXCRETION;

EID: 80055083188     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00663.2010     Document Type: Article

References (43)

1. Alfrey AC. Effect of dietary phosphate restriction on renal function and deterioration. Am J Clin Nutr 47: 153-156, 1988.
2. Alfrey AC, Karlinsky M, Haut L. Protective effect of phosphate restriction on renal function. Adv Exp Med Biol 128: 209-218, 1980.
3. Angrand PO, Daigle N, van der Hoeven F, Scholer HR, Stewart AF. Simplified generation of targeting constructs using ET recombination. Nucleic Acids Res 27: e16, 1999.
4. Arima K, Hines ER, Kiela PR, Drees JB, Collins JF, Ghishan FK. Glucocorticoid regulation and glycosylation of mouse intestinal type IIb Na-Pi cotransporter during ontogeny. Am J Physiol Gastrointest Liver Physiol 283: G426-G434, 2002.
5. Berndt T, Kumar R. Novel mechanisms in the regulation of phosphorus homeostasis. Physiology (Bethesda) 24: 17-25, 2009.
6. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 31: 607-617, 1998.
7. Brown SA, Crowell WA, Barsanti JA, White JV, Finco DR. Beneficial effects of dietary mineral restriction in dogs with marked reduction of functional renal mass. J Am Soc Nephrol 1: 1169-1179, 1991.
8. Fukagawa M, Kazama JJ. FGF23: its role in renal bone disease. Pediatr Nephrol 21: 1802-1806, 2006.
9. Giral H, Caldas Y, Sutherland E, Wilson P, Breusegem S, Barry N, Blaine J, Jiang T, Wang XX, Levi M. Regulation of rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol 297: F1466-F1475, 2009.
10. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342: 1478-1483, 2000.
11. Hattenhauer O, Traebert M, Murer H, Biber J. Regulation of small intestinal Na-Pi type IIb cotransporter by dietary phosphate intake. Am J Physiol Gastrointest Liver Physiol 277: G756-G762, 1999.
12. Haut LL, Alfrey AC, Guggenheim S, Buddington B, Schrier N. Renal toxicity of phosphate in rats. Kidney Int 17: 722-731, 1980.
13. Hruska KA, Choi ET, Memon I, Davis TK, Mathew S. Cardiovascular risk in chronic kidney disease (CKD): the CKD-mineral bone disorder (CKD-MBD). Pediatr Nephrol 25: 769-778, 2010.
14. Hruska KA, Mathew S, Lund R, Qiu P, Pratt R. Hyperphosphatemia of chronic kidney disease. Kidney Int 74: 148-157, 2008.
15. Ibels LS, Alfrey AC, Haut L, Huffer WE. Preservation of function in experimental renal disease by dietary restriction of phosphate. N Engl J Med 298: 122-126, 1978.
16. +-dependent phosphate cotransporters. Pflügers Arch 461: 77-90, 2011.
17. Karlinsky ML, Haut L, Buddington B, Schrier NA, Alfrey AC. Preservation of renal function in experimental glomerulonephritis. Kidney Int 17: 293-302, 1980.
18. Kusano K, Segawa H, Ohnishi R, Fukushima N, Miyamoto K. Role of low protein and low phosphorus diet in the progression of chronic kidney disease in uremic rats. J Nutr Sci Vitaminol (Tokyo) 54: 237-243, 2008.
19. Loghman-Adham M. Role of phosphate retention in the progression of renal failure. J Lab Clin Med 122: 16-26, 1993.
20. Loghman-Adham M. Safety of new phosphate binders for chronic renal failure. Drug Saf 26: 1093-1115, 2003.
21. Lumlertgul D, Burke TJ, Gillum DM, Alfrey AC, Harris DC, Hammond WS, Schrier RW. Phosphate depletion arrests progression of chronic renal failure independent of protein intake. Kidney Int 29: 658-666, 1986.
22. Marks J, Churchill LJ, Srai SK, Biber J, Murer H, Jaeger P, Debnam ES, Unwin RJ. Intestinal phosphate absorption in a model of chronic renal failure. Kidney Int 72: 166-173, 2007.
23. Mathew S, Lund RJ, Strebeck F, Tustison KS, Geurs T, Hruska KA. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol 18: 122-130, 2007.
24. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, Hruska KA. The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol 19: 1092-1105, 2008.
25. Matsuo A, Negoro T, Seo T, Kitao Y, Shindo M, Segawa H, Miyamoto K. Inhibitory effect of JTP-59557, a new triazole derivative, on intestinal phosphate transport in vitro and in vivo. Eur J Pharmacol 517: 111-119, 2005.
26. Miyamoto K, Ito M, Kuwahata M, Kato S, Segawa H. Inhibition of intestinal sodium-dependent inorganic phosphate transport by fibroblast growth factor 23. Ther Apher Dial 9: 331-335, 2005.
27. Miyamoto K, Ito M, Tatsumi S, Kuwahata M, Segawa H. New aspect of renal phosphate reabsorption: the type IIc sodium-dependent phosphate transporter. Am J Nephrol 27: 503-515, 2007.
28. Murer H, Forster I, Biber J. The sodium phosphate cotransporter family SLC34. Pflügers Arch 447: 763-767, 2004.
29. Murer H, Hernando N, Forster I, Biber J. Proximal tubular phosphate reabsorption: molecular mechanisms. Physiol Rev 80: 1373-1409, 2000.
30. Murer H, Hernando N, Forster L, Biber J. Molecular mechanisms in proximal tubular and small intestinal phosphate reabsorption (plenary lecture). Mol Membr Biol 18: 3-11, 2001.
31. Murer H, Markovich D, Biber J. Renal and small intestinal sodiumdependent symporters of phosphate and sulphate. J Exp Biol 196: 167-181, 1994.
32. Muyrers JP, Zhang Y, Testa G, Stewart AF. Rapid modification of bacterial artificial chromosomes by ET-recombination. Nucleic Acids Res 27: 1555-1557, 1999.
33. +-Pi cotransporter in mouse small intestine. Am J Physiol Gastrointest Liver Physiol 288: G496-G500, 2005.
34. Sabbagh Y, O'Brien SP, Song W, Boulanger JH, Stockmann A, Arbeeny C, Schiavi SC. Intestinal npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol 20: 2348-2358, 2009.
35. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N. Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280: 2543-2549, 2005.
36. Segawa H, Kaneko I, Takahashi A, Kuwahata M, Ito M, Ohkido I, Tatsumi S, Miyamoto K. Growth-related renal type II Na/Pi cotransporter. J Biol Chem 277: 19665-19672, 2002.
37. Segawa H, Kaneko I, Yamanaka S, Ito M, Kuwahata M, Inoue Y, Kato S, Miyamoto K. Intestinal Na-Pi cotransporter adaptation to dietary Pi content in vitamin D receptor null mice. Am J Physiol Renal Physiol 287: F39-F47, 2004.
38. +-dependent Pi-co-transporter, NaPi-IIb, results in early embryonic lethality. Biochem Biophys Res Commun 381: 482-486, 2009.
39. Veldman CM, Schlapfer I, Schmid C. 1 Alpha,25-dihydroxyvitamin D3 stimulates sodium-dependent phosphate transport in osteoblast-like cells. Bone 21: 41-47, 1997.
40. Xu H, Bai L, Collins JF, Ghishan FK. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)2 vitamin D3. Am J Physiol Cell Physiol 282: C487-C493, 2002.
41. Xu H, Uno JK, Inouye M, Collins JF, Ghishan FK. NF1 transcriptional factor(s) is required for basal promoter activation of the human intestinal NaPi-IIb cotransporter gene. Am J Physiol Gastrointest Liver Physiol 288: G175-G181, 2005.
42. Xu H, Uno JK, Inouye M, Xu L, Drees JB, Collins JF, Ghishan FK. Regulation of intestinal NaPi-IIb cotransporter gene expression by estrogen. Am J Physiol Gastrointest Liver Physiol 285: G1317-G1324, 2003.
43. Yeh JK, Aloia JF. Effect of glucocorticoids on the passive transport of phosphate in different segments of the intestine in the rat. Bone Miner 2: 11-19, 1987.